Strontium-89 (89Sr) analgesia for rare thymic carcinoid tumor with bony metastases

Tal H. Vishne, Ilan G. Ron

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


The authors report the cases of two patients in whom strontium-89 (89Sr) was used to relieve diffuse metastatic bone pain. The type of cancer involved, thymic carcinoid tumor, is itself rare and the risk of its metastasizing to the bone is very low. Both patients showed a measure of response to treatment, suggesting that this analgesic method has value for some patients. The marked benefit of one patient for a total of 9 months was attributable to two 89Sr injections, whereas the other patient improved for only 5 weeks after one injection.

Original languageEnglish
Pages (from-to)602-604
Number of pages3
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Issue number6
StatePublished - Dec 1998
Externally publishedYes


  • Analgesic method
  • Metastatic bone pain
  • Strontium-89
  • Thymic carcinoid


Dive into the research topics of 'Strontium-89 (89Sr) analgesia for rare thymic carcinoid tumor with bony metastases'. Together they form a unique fingerprint.

Cite this